On June 16, 2025 Biosceptre reported that lead scientists Alex Joechner and Dr. Cindy Li from the Biosceptre Laboratory were honoured with an invitational oral presentation at the European Hematology Association (EHA) (Free EHA Whitepaper) 2025 Annual Congress, held this week in Milan (Press release, Biosceptre, JUN 16, 2025, View Source;utm_medium=rss&utm_campaign=biosceptre-presenting-our-aml-modular-car-t-program-at-the-prestigious-european-hematological-congress [SID1234654004]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

With more than 14,000 delegates in attendance, EHA (Free EHA Whitepaper) is one of the world’s premier events for hematological research. Of the more than 3,500 abstracts submitted last year, only 235 were selected for oral presentation—highlighting the exceptional quality and impact of the work presented by our team.

The 15-minute oral presentation showcased compelling new data on Biosceptre’s modular CAR-T platform, focusing on its function and therapeutic potential in treating Acute Myeloid Leukemia (AML). This recognition reflects the scientific strength of our BRiDGECAR program and the dedication of our team in advancing next-generation cell therapies for challenging blood cancers.

We congratulate Alex and Dr. Li on this achievement and thank the EHA (Free EHA Whitepaper) for the opportunity to present on the global stage.